Menu
Back to Journals » Clinical Ophthalmology » Volume 13
Descemet membrane endothelial keratoplasty (DMEK): an update on safety, efficacy and patient selection
Authors Trindade BLC, Eliazar GC
Received 5 June 2019
Accepted for publication 1 August 2019
Published 16 August 2019 Volume 2019:13 Pages 1549—1557
DOI https://doi.org/10.2147/OPTH.S178473
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Bruno Lovaglio Cançado Trindade,1–3 Glauber Coutinho Eliazar3,4
1Cançado Trindade Eye Institute, Belo Horizonte, Brazil; 2Medical Science School of Medicine - FELUMA, Belo Horizonte, Brazil; 3Cornea Department, Medical Sciences University Hospital Eye Institute, Belo Horizonte, Brazil; 4Cornea Department, Santa Casa Eye Clinic, Belo Horizonte, Brazil
Correspondence: Bruno Lovaglio Cançado Trindade
Cançado Trindade Eye Institute, Rua Manaus, 595, 30.150-350 Belo Horizonte, MG, Brazil
Tel +55 3 13 241 5544
Email bruno.trindade@ioct.org
Abstract: Descemet membrane endothelial keratoplasty (DMEK) is gaining popularity worldwide as a procedure to address corneal endothelial dysfunctions. Its perfect anatomical result improves outcomes and expedites visual recovery. This review addresses important aspects of safety, efficacy and patient selection.
Keywords: descemet membrane endothelial keratoplasty (DMEK), complications, safety, indication, patient selection
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.